Medications for Perennial Allergic Rhinitis

7 results
Foxland Pharmaceuticals, Inc.
Usage: Carbinoxamine maleate is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, vasomotor rhinitis, allergic conjunctivitis, mild allergic skin reactions, dermatographism, and as an adjunct therapy for anaphylactic reactions after acute symptoms have been controlled. It also helps reduce allergic reaction severity to blood or plasma.
Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.
Usage: Cetirizine hydrochloride oral solution is indicated for relieving symptoms of perennial allergic rhinitis and treating uncomplicated skin manifestations of chronic idiopathic urticaria in children aged 6 months to 23 months. It effectively addresses sneezing, runny nose, and hives, reducing their occurrence and severity.
APOZEAL PHARMACEUTICALS INC
Usage: Cetirizine Hydrochloride Oral Solution is indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 to 23 months, and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in children aged 6 months to 5 years, reducing hives and itching.
Akorn
Usage: Fluticasone propionate nasal spray is indicated for managing nasal symptoms of perennial nonallergic rhinitis in adults and children aged 4 years and older.
Apotex Corp.
Usage: Ipratropium bromide nasal solution, 0.03% is used to relieve rhinorrhea in adults and children aged 6 and older with allergic and nonallergic perennial rhinitis. It does not address nasal congestion, sneezing, or postnasal drip.
Proficient Rx LP
Usage: Levocetirizine dihydrochloride tablets are indicated for relieving symptoms of perennial allergic rhinitis in children aged 6 months to 2 years and for treating uncomplicated skin manifestations of chronic idiopathic urticaria in individuals 6 months and older.
Chartwell RX, LLC
Usage: Levocetirizine dihydrochloride oral solution is indicated for relief of perennial allergic rhinitis symptoms in children aged 6 months to 2 years, and for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months and older.